论文部分内容阅读
目的:分析血液透析治疗终末期肾病高血压的临床疗效。方法:随机抽取终末期肾病高血压患者80例,按照治疗方式的不同分为对照组及治疗组各40例,对照组患者接受普通血液透析,治疗组患者接受高通量血液透析,对比两组血压控制情况。结果:治疗组透析后收缩压(SBP)、舒张压(DBP)及平均动脉压(MAP)较对照组低,透析后甲状旁激素(i PTH)、肾素(RA)、血管紧张素Ⅱ(AngⅡ)明显低于对照组(P<0.05),治疗组不良反应发生率5%,对照组不良反应发生率7.5%(P>0.05)。结论:血液透析治疗终末期肾病高血压均具有一定效果,但高通量血液透析降压效果更为显著。
Objective: To analyze the clinical effect of hemodialysis in the treatment of end-stage renal hypertension. Methods: A total of 80 patients with end stage renal disease were randomly divided into control group and treatment group according to different treatment methods. Patients in control group received general hemodialysis. Patients in treatment group received high-throughput hemodialysis. Blood pressure control. Results: The SBP, DBP and MAP in the treatment group were lower than those in the control group after dialysis, and the levels of i PTH, RA and angiotensin Ⅱ AngⅡ) was significantly lower than that of the control group (P <0.05). The incidence of adverse reactions in the treatment group was 5% and that in the control group was 7.5% (P> 0.05). Conclusion: Hemodialysis has some effect on the treatment of end stage renal disease, but the antihypertensive effect of high-flux hemodialysis is more obvious.